Braveheart Bio, Inc. · NASDAQ:BRVE

Orbimed Advisors LLC reported a 13.50% stake in Braveheart Bio, Inc. (Schedule 13D/A)

Event Sep 8, 2026 · Filed Sep 10, 2026

Orbimed Advisors LLC reported a 13.50% stake in Braveheart Bio, Inc., 12,175,159 shares, with active intent on Sep 8, 2026. Filed Sep 10, 2026 (Schedule 13D/A).

Stake
13.50%
Shares
12,175,159
Intent
Active
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
ORBIMED ADVISORS LLC13.50%12,175,159
OrbiMed Capital GP IX LLC13.20%11,901,826
OrbiMed Genesis GP LLC0.30%273,333

Source

View original at SEC

Related